Zymeworks Inc.

Zymeworks Appoints Computational Antibody Design Expert Dr. Bruce Tidor to its Scientific Advisory Board

October 2, 2009

Zymeworks has appointed Dr. Bruce Tidor from the Massachusetts Institute of Technology to its scientific advisory board. Press Release

Zymeworks Closes $3.5 Million Round of Financing and Announces Changes to its Board of Directors

June 23, 2009

Zymeworks Inc., a privately held computational biotechnology company, today announced the close of a financing totaling $3.5 million. The financing included an institutional investment by CTI Life Sciences Fund (“CTI”) and the completion of its existing private financing round. Further financial terms are not disclosed. Zymeworks will use the proceeds to fund ongoing validation and research programs leading to the advancement of Zymeworks’ protein therapeutics pipeline.

In conjunction with the financing, Dr. Shermaine Tilley of CTI and Mr. Kenneth Galbraith of Ventures West Management Inc. will be joining the Board of Directors. Dr. Andrew Wright and Mr. Amos Michelson will be stepping down as directors but will retain board observer status. Press Release

Zymeworks and XOMA to Collaborate on Antibody Research Program

May 15th, 2009

Zymeworks today announced it has entered into a research agreement with California-based XOMA Ltd. to optimize an undisclosed antibody using Zymeworks’ ZymeCAD™ suite of predictive protein engineering tools and XOMA’s innovative Targeted Affinity Enhancement™ (TAE™) technology for antibody mutagenesis and optimization. Press Release

Zymeworks Awarded BIOTECanada's Gold Leaf Award as Early Stage Company of the Year'

May 13th, 2009

Zymeworks is the recipient of BIOTECanada's prestigious Gold Leaf Award in the category of Early Stage Company of the Year - Industrial & Agricultural. Press Release

Zymeworks Appoints Dr. Paul J. Carter to its Scientific Advisory Board

April 14th, 2009

Zymeworks has added Dr. Paul J. Carter of VLST Corp. to its scientific advisory board. Press Release

Zymeworks Scientist Publishes in Noted Journal

March 3, 2009

Zymeworks' Dr. Yuqing Deng published an article entitled “Computations of Standard Binding Free Energies with Molecular Dynamics Simulations” as a centennial feature article in the February 26 issue of the prestigious Journal of Physical Chemistry B. The cover of the issue features graphics generated by Dr. Deng in the course of his research. Press Release